Related Experiment Video
Updated: Jul 10, 2026

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates
Published on: April 22, 2019
Terrein inhibits keratinocyte proliferation via ERK inactivation and G2/M cell cycle arrest
Dong-Seok Kim1, Hyun-Kyung Lee, Seo-Hyoung Park
1Department of Biochemistry, College of Medicine, Chung-Ang University, Republic of Korea.
Abstract:
Terrein, a fungal metabolite, has been recently shown to have a strong antiproliferative effect on skin equivalents. In the present study, we further investigated the effects of terrein on the possible signalling pathways involved in the growth inhibition of human epidermal keratinocytes by examining the regulations of extracellular signal-regulated protein kinase (ERK) and of the Akt pathway by terrein. It was observed that ERK was inactivated by terrein and that keratinocyte proliferation was inhibited, whereas Akt was unaffected. The inhibition of the ERK pathway by U0126 (a specific ERK inhibitor) also had a dose-dependent antiproliferative effect on human keratinocytes. These results indicate that ERK inhibition is involved in keratinocyte growth inhibition by terrein. Moreover, flow cytometric analysis showed that terrein inhibits DNA synthesis, as evidenced by a reduction in the S phase and an increase in the G2/M phase of the cell cycle. Thus, we next examined changes in the expressions of G2/M cell cycle-related proteins. Terrein was found to downregulate cyclin B1 and Cdc2 without Cdc2 phosphorylation, but upregulated p27(KIP1) (p27), a known inhibitor of cyclin-dependent kinase. These results suggest that terrein reduces human keratinocyte proliferation by inhibiting ERK and by decreasing the expressions of cyclin B1 and Cdc2 complex.
Insights
The fungal metabolite terrein inhibits human keratinocyte proliferation by inactivating the extracellular signal-regulated kinase (ERK) pathway. This leads to cell cycle arrest and reduced DNA synthesis, revealing a novel mechanism for terrein
Area of Science:
- Molecular Biology
- Dermatology
- Mycology
Background:
- Terrene, a fungal metabolite, exhibits significant antiproliferative activity on skin equivalents.
- Understanding the molecular mechanisms behind terrein's effects on human epidermal keratinocytes is crucial.
Purpose of the Study:
- To investigate the signaling pathways, specifically extracellular signal-regulated protein kinase (ERK) and Akt, affected by terrein in human epidermal keratinocytes.
- To elucidate the role of these pathways in terrein-induced growth inhibition.
Main Methods:
- Treatment of human epidermal keratinocytes with terrein.
- Analysis of ERK and Akt pathway activation using Western blotting.
- Cell cycle analysis via flow cytometry.
- Examination of cell cycle-related protein expression (cyclin B1, Cdc2, p27).
Main Results:
- Terrene inactivated the ERK pathway, leading to keratinocyte proliferation inhibition; the Akt pathway remained unaffected.
- Terrene treatment resulted in reduced DNA synthesis, with cells accumulating in the G2/M phase of the cell cycle.
- Terrene downregulated cyclin B1 and Cdc2 expression while upregulating p27(KIP1), a cyclin-dependent kinase inhibitor.
Conclusions:
- Extracellular signal-regulated kinase (ERK) pathway inhibition is a key mechanism by which terrein reduces human keratinocyte proliferation.
- Terrene induces cell cycle arrest at the G2/M phase by modulating the expression of key cell cycle regulators.
- These findings highlight terrein's potential as an antiproliferative agent targeting keratinocyte growth.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Mitogens and the Cell Cycle
Negative Regulator Molecules
Renewal of Skin Epidermal Stem Cells
Abnormal Proliferation

